Loading…

471 Inhibiting signalling by erbB receptor tyrosine kinases with AZD8931, a potent reversible small molecule inhibitor, reduces intestinal adenoma formation in the ApcMin/+ mouse model

Saved in:

Bibliographic Details
Published in:	European journal of cancer supplements 2010, Vol.8 (7), p.151-151
Main Authors:	Alferez, D, Logié, A, Seedhar, P, Poulsom, R, Klinowska, T, Wilkinson, R.W
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!